Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2016

Lonetti Annalisa, Fontana Maria Chiara, Martinelli Giovanni, Iacobucci Ilaria

Abstract excerpt

Genetic variations in patients have strong impact on their drug therapies and responses because the variations may contribute to the efficacy and/or produce undesirable side effects for any given drug. The Drug Metabolizing Enzymes and Transporters (DMET) assay is a high-throughput technology by Affymetrix that is able to simultaneously genotype variants in multiple genes involved in absorption, distribution,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA
Share to Genetic Markers
Share to Nucleic Acid Amplification Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Software

Share to Staining and Labeling

Share to Statistics as Topic

Source

Identifiers

PMID: 26614074
DOI: 10.1007/978-1-4939-3136-1_11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies.PMID 26614074Read ↗

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.Semantic proximity Read ↗

Pharmacogenomics: translating functional genomics into rational therapeutics.Semantic proximity Read ↗

[SNP collection, pharmacogenomics, and the future of drug therapy].Semantic proximity Read ↗

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineSemantic proximity Read ↗

Clinical Pharmacology and Pharmacogenetics in a Genomics Era: The DMET PlatformSemantic proximity Read ↗

Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Semantic proximity Read ↗

The Affymetrix DMET platform and pharmacogenetics in drug development.Semantic proximity Read ↗

Pharmacogenomics of membrane transporters: past, present and future.Semantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

Pharmacogenomics in the clinic.Semantic proximity Read ↗

Genome-based pharmacogenetics and the pharmaceutical industry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.